Ernexa Therapeutics Inc.

ERNANASDAQHealthcare● Active

$7.39

$-0.50(-6.34%)

Market Cap$2321376

P/E Ratio—

52W High$71.5

52W Low$3.18

Avg Volume1.6M

Open$7.93

Beta2.50

Overview

Ernexa Therapeutics Inc. (ERNA) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ERNA · net income · updated Jun 9, 2026

Core profitability metrics

ERNA · net income · margin · TTM · CAGR

Net income was −$14.1M for FY2025 (fiscal year ending 2025-12-31), up 68.4% year-over-year. Net profit margin was —. Based on available data, Ernexa Therapeutics Inc. has been profitable since at least 2020.

FY2025 Net Income−$14.1M▲ +68.4% YoY

Trailing 12M (TTM)−$11.4Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+68.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2020

▸ FMP /income-statement · Annual · ERNA net income history · ERNA profit margin

Annual net income data

ERNA · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$14.1M▲ +68.4%—$0

FY2024Loss−$44.5M▼ 105.6%-7652.8%$582,000

FY2023Loss−$21.7M▲ +11.8%-31864.7%$68,000

FY2022Loss−$24.6M▲ +79.9%—$0

FY2021Loss−$122.5M▼ 1129.3%—$0

Net income vs peers (Healthcare)

ERNA vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Ernexa Therapeutics Inc.YOU

ERNA

−$14.1M+68.4%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Ernexa Therapeutics Inc. (ERNA) reported net income of −$14.1M for FY2025 (fiscal year ending 2025-12-31), up 68.4% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Ernexa Therapeutics Inc. has been profitable since at least 2020. Net income reached a peak of $11.9M in FY2020. Data available for 11 fiscal years.

Ernexa Therapeutics Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Ernexa Therapeutics Inc. net worth" — the company's market capitalization is a separate figure from ERNA net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ERNA net income · 4 questions

Ernexa Therapeutics Inc. is not currently profitable on an annual basis. The company reported a net loss of $14.1M for FY2025.

is ERNA profitabledoes ERNA make a profitERNA profitabilityERNA profitable company

▸ Source: FMP /income-statement · GAAP · Ernexa Therapeutics Inc. · Ernexa Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026